Steris traded at $252.16 this Friday February 6th, increasing $8.35 or 3.42 percent since the previous trading session. Looking back, over the last four weeks, Steris gained 2.72 percent. Over the last 12 months, its price rose by 12.96 percent. Looking ahead, we forecast Steris to be priced at 254.51 by the end of this quarter and at 231.71 in one year, according to Trading Economics global macro models projections and analysts expectations.
Steris plc, formerly Steris Ltd, is a provider of infection prevention and other procedural products and services. The Company offers a mix of capital equipment products, such as sterilizers and washers, surgical tables, lights and equipment management systems and connectivity solutions, such as operating room integration; consumable products, such as detergents and gastrointestinal endoscopy accessories and other products; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory services and outsourced reprocessing. The Company operates through four reportable business segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. It’s Corporate and other segment includes the Defense and Industrial business unit. The Company serves the customers in the United Kingdom, the United States and many other countries throughout the world.